Immunological status of patients with bladder cancers (transitional cell tumours).
D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012882:Skin Tests; D001749:Urinary Bladder Neoplasms / Q000276:immunology*